Webinar: EDCTP-AIGHD Special Session at the Virtual Global Forum on TB Vaccines: Launch of a Global Roadmap
The Global TB Vaccine R&D Roadmap was commissioned by the European & Developing Countries Clinical Trials Partnership (EDCTP) to the Amsterdam Institute for Global Health and Development (AIGHD) to identify priorities to coordinate global action to accelerate the development and implementation of new TB vaccines. The Roadmap has been developed through an iterative global consultative process designed to identify the key barriers to TB vaccine R&D and implementation, and potential ways in which they might be overcome. It is intended to provide a shared set of priorities to guide the activities of all stakeholders with an interest in TB vaccine development and use.AIGHD and EDCTP are pleased to invite the global TB vaccine community and interested stakeholders to attend the official launch of the Roadmap. The session opens with an introduction to the Roadmap, followed by an overview of current challenges and opportunities for TB vaccine R&D, and the perspective from a community representative. The presentations will be followed by a panel discussion with a diverse group of stakeholders, each sharing their comments on the Roadmap, their views on how they are planning to use it, and how they consider it can guide the future development of TB vaccines.
When: 20 April 2021, 18:00-19:30 CEST
Where: Virtual (Zoom)
REGISTER NOW: https://zoom.us/webinar/register/WN_pbpKgGpRR6ejZN1B-i0bxQ
Articles
Test Article With Image
Test article 14 July 2025 with image TL
Read moreVirtual Workshop: Recognition And Control Of Mtb Infected Cells: From Basics To The Clinic | 13 – 14June 2023
The Stop
TB Partnership Working Group on New TB Vaccines (WGNV) and the National
Institute for Allergy and Infectious Diseases (NIAID)are
co-hosting a workshop on the topic of Recognition and Control of Mtb
Infected Cells: From Basics to the Clinic. This workshop is intended to address
the need for correlates and to identify platforms that measure recognition or
control of the infected cell - especially in humans - as identified in the EDCTP/AIGHD Global Roadmap for
Research and Development of New TB Vaccines and the Strategic Framework for
New TB Vaccines in the Stop TB Partnership Global Plan to End TB 2023 - 2030.
The overall goals of this workshop
are to:
- elucidate the mechanisms by
which the immune system recognizes the Mtb-infected cell
- explore the degree to which
such recognition can lead to control of the intracellular microbe, and
- discuss the translational
implications of these observations
The workshop format will be largely
discussion-based. Each session will have three short presentations that will
provide a high-level overview of key topics within the session theme, followed
by a discussion between the session chairs, speakers, and participants.
Click here
to view the programme and
speakers.
This workshop is free of charge and
open to any participants interested in this topic.
Ssi/Isid Infectious Diseases Research Fellowships | Deadline For Applications: 16 June 2023
The International Society for Infectious Diseases (ISID) and the Swiss
Society for Infectious Diseases (SSI) are inviting applications for their joint
Infectious Diseases Research Fellowship Program. The purpose of this programme
is to support infectious disease physicians and scientists from under-resourced
countries through multidisciplinary clinical and laboratory training at a
select biomedical institution in Zurich, Switzerland. The one-year SSI/ISID
Fellowship programme is open to applicants who are 40 years or younger,
citizens and permanent residents of under-resourced countries or Eastern
Europe. The deadline for applications is 16 June 2023.
More information: https://na.eventscloud.com/eSites/748378/Homepage